We use cookies to ensure that we give you the best experience on our website Learn more

Home

Saved research

Submission

02 - TREATMENT AND MANAGEMENT OF PATIENTS WITH CARDIOVASCULAR DISEASE IN GENERAL PRACTISE: UNDERDIAGNOSIS AND UNDERTREATMENT

Submitted

and 1 other(s)

23 Views
0 Downloads
0 Saves

Presented at

87th EAS Congress

-

Presentation

thumbnail

Abstract

Background and Aims: The Danish Heart Association estimates that approximately 10% of the Danish adult population have experienced one or more cardiovascular events. According to ESC Prevention Guidelines, LDL should be reduced to a level of < 1.8 mmol/L (70 mg/dl) or at least 50% from baseline. In Denmark, following a cardiovascular event, patients are offered a rehabilitation programme and then discharged to follow up by their regular general practitioner (GP). In this study we examined the extent of lipid lowering therapy (LLT) and if the patients reach their LDL target level. Methods: By screening the patient records of individuals aged 18-100 years at six GP clinics in Copenhagen we identified a CVD population with one or more measurements of LDL. In this population we registered information about LDL levels (maximum and the latest follow up), LLT and diagnoses of ischaemic heart disease, stroke and/or peripheral artery disease. Results A total of 9,651 individuals were evaluated. In the population 278 individuals suffered CVD, corresponding to 2.88% (CI [2.54;3.21]). Of these patients 229 had one or more LDL measurements. Even though a significant reduction of LDL was observed in both patients with or without active LLT, only 26.2% (CI [20.5-31.9]) reached their LDL-C target. Conclusions: It would appear that a large proportion of CVD patients in general practice are not registered properly, and those who are registered do not meet their treatment target in respects to LDL. Furthermore, less than a third of the estimated CVD patients were registered.

Datasets

No datasets are available for this submission.

License

No license information is available for this submission.

Company

Legal

Follow us

© Copyright 2019 Morressier GmbH. All rights reserved.

© Copyright 2019 Morressier GmbH.
All rights reserved.